We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+11.14%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$468M
AUM Growth
+$67.5M
Cap. Flow
+$29.5M
Cap. Flow %
6.31%
Top 10 Hldgs %
41.39%
Holding
86
New
11
Increased
45
Reduced
11
Closed
5

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.16M
2
UNP icon
Union Pacific
UNP
+$2.12M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.93M
4
LLY icon
Eli Lilly
LLY
+$1.81M
5
AMZN icon
Amazon
AMZN
+$1.73M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.01M
2
CHD icon
Church & Dwight Co
CHD
+$2.72M
3
NVDA icon
NVIDIA
NVDA
+$1.04M
4
AMD icon
Advanced Micro Devices
AMD
+$767K
5
EW icon
Edwards Lifesciences
EW
+$767K

Sector Composition

Rank Sector Weight
1 Technology 30.7%
2 Healthcare 17.79%
3 Industrials 12.47%
4 Consumer Discretionary 9.58%
5 Communication Services 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$185B
$4.1M 0.88%
23,442
+1,250
+6% +$210K
NKE icon
27
Nike
NKE
$64.5B
$3.85M 0.82%
41,005
+5,765
+16% +$586K
MDT icon
28
Medtronic
MDT
$107B
$3.01M 0.64%
34,528
+1,120
+3% +$95.6K
MRK icon
29
Merck
MRK
$307B
$2.85M 0.61%
21,569
+13,944
+183% +$1.72M
UNP icon
30
Union Pacific
UNP
$176B
$2.82M 0.6%
11,480
+8,629
+303% +$2.12M
HON icon
31
Honeywell
HON
$71.7B
$2.71M 0.58%
14,002
-2,377
-15% -$448K
MRNA icon
32
Moderna
MRNA
$23.6B
$2.3M 0.49%
21,600
+12,000
+125% +$1.21M
ABBV icon
33
AbbVie
ABBV
$448B
$2.3M 0.49%
12,612
+1,673
+15% +$288K
NVS icon
34
Novartis
NVS
$285B
$2.11M 0.45%
21,834
-6,126
-22% -$628K
ABNB icon
35
Airbnb
ABNB
$86B
$2.1M 0.45%
12,721
+1,427
+13% +$216K
ADBE icon
36
Adobe
ADBE
$93.3B
$2.07M 0.44%
4,103
+2,091
+104% +$1.2M
LLY icon
37
Eli Lilly
LLY
$1.02T
$1.98M 0.42%
+2,545
New +$1.81M
CRWD icon
38
CrowdStrike
CRWD
$202B
$1.93M 0.41%
24,060
+8,000
+50% +$612K
HUBS icon
39
HubSpot
HUBS
$11.8B
$1.88M 0.4%
3,000
+1,000
+50% +$601K
SPTM icon
40
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.8M 0.38%
28,000
-1,000
-3% -$61K
APTV icon
41
Aptiv
APTV
$12.1B
$1.73M 0.37%
21,728
+132
+0.6% +$10.6K
GOOG icon
42
Alphabet (Google) Class C
GOOG
$4.29T
$1.53M 0.33%
+10,045
New +$1.45M
BDX icon
43
Becton Dickinson
BDX
$42.6B
$1.38M 0.29%
5,560
+1,005
+22% +$241K
KO icon
44
Coca-Cola
KO
$353B
$1.33M 0.28%
21,666
+16,416
+313% +$986K
CARR icon
45
Carrier Global
CARR
$55.6B
$1.19M 0.25%
+20,398
New +$1.15M
TT icon
46
Trane Technologies
TT
$103B
$1.18M 0.25%
3,915
BALL icon
47
Ball Corp
BALL
$16.6B
$1.1M 0.24%
+16,360
New +$995K
PBA icon
48
Pembina Pipeline
PBA
$29.5B
$1.08M 0.23%
30,524
+4,400
+17% +$152K
ZS icon
49
Zscaler
ZS
$24.2B
$963K 0.21%
5,000
+3,000
+150% +$671K
PFE icon
50
Pfizer
PFE
$141B
$959K 0.2%
34,550
+27,396
+383% +$760K

Similar funds

Brian C. Broderick's Q1 2024 Portfolio in Review

As of Q1 2024, Brian C. Broderick held 86 positions worth $468M, up 17% from $401M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Brian C. Broderick deployed $29.5M of net new capital in Q1 2024, opening 11 new positions and adding to 45 existing holdings. Its largest new stake was Eli Lilly: 2,545 shares worth $1.98M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was NVIDIA, an estimated $1.04M trimmed.

  • Brian C. Broderick's largest Q1 2024 buy was Eli Lilly: 2,545 shares worth $1.98M.
  • Brian C. Broderick added most to Procter & Gamble in Q1 2024, an estimated $2.16M increase.
  • Brian C. Broderick's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.04M.
  • Brian C. Broderick fully exited CVS Health in Q1 2024, selling an estimated $3.01M.
  • Brian C. Broderick's ten largest holdings make up 41% of its $468M portfolio in Q1 2024.
  • Brian C. Broderick opened 11 new positions and closed 5 in Q1 2024.
  • Brian C. Broderick's portfolio value rose 17% quarter-over-quarter to $468M.

Based on Brian C. Broderick's 13F filing for Q1 2024, filed 6 May 2024.